phenylalanine has been researched along with Neurilemoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hermans, R; Jääskeläinen, J; Järviluoma, E; Kallio, M; Kulvik, M; Laakso, J; Paetau, A; Rasilainen, M; Ruokonen, I; Seppälä, M; Vähätalo, J | 1 |
Eskola, O; Havu-Aurén, K; Jääskeläinen, J; Kiiski, J; Kulvik, M; Lehtiö, K; Minn, H; Oikonen, V; Vähätalo, J; Vuorinen, V | 1 |
Sui, X; Xu, F; Xu, M; Zhao, R; Zhao, ZJ | 1 |
3 other study(ies) available for phenylalanine and Neurilemoma
Article | Year |
---|---|
Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.
Topics: Adult; Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Feasibility Studies; Female; Fructose; Humans; Infusions, Intravenous; Male; Meningioma; Middle Aged; Neurilemmoma; Phenylalanine; Tissue Distribution; Young Adult | 2015 |
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
Topics: Adult; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurilemmoma; Neurofibromatoses; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Tyrosine phosphorylation of myelin P(0) and its implication in signal transduction.
Topics: Amino Acid Sequence; Animals; Animals, Newborn; Brain; Cell Line; Cloning, Molecular; Consensus Sequence; Humans; Mice; Mice, Inbred BALB C; Mutagenesis, Site-Directed; Myelin P0 Protein; Neurilemmoma; Phenylalanine; Phosphorylation; Phosphotyrosine; Recombinant Proteins; Sequence Alignment; Signal Transduction; Transfection; Tumor Cells, Cultured; Tyrosine; Vanadates | 2000 |